$18.91
+0.67 (+3.67%)
NOV News6 articles
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.
GE Vernova Surges 5.6% as Energy Infrastructure Demand Fuels Rally
GE Vernova shares climbed to $779.35 amid a broader market rally, buoyed by new wind orders and a strategic alliance. Analysts highlight the early-stage energy infrastructure cycle but note wind segment risks.
Novartis Shares Approach 52-Week Peak Amid San Diego Research Expansion
Novartis stock neared a 52-week high after breaking ground on a major San Diego research center, while investors eye upcoming shareholder events and 2026 profit guidance.
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.
GE Vernova Surges 5.6% on Wind Orders and Acquisition Close
GE Vernova shares climbed nearly 6% Friday following new U.S. wind repower orders and completion of a major transformer acquisition. Investors await key U.S. economic data next week.
Novartis Advances with Canadian Reimbursement and Major U.S. R&D Expansion
Novartis shares gained as the company secured a draft reimbursement nod in Canada for Kisqali and broke ground on a $23 billion U.S. research center. Investors eye upcoming dividend and annual meeting.